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Conclusions: Reanastomosis of the divided left renal
vein undergoing AAA repair does not provide any long-
term advantage over ligation in patients with either normal
or slightly abnormal preoperative renal function.
Comparison of patient characteristics between groups.
RLRV (n10) LLRV (n14) P-value
Age (Mean  SD) 70  4.0 69.5  10.9 ns
Gender (% male) 80% (8) 85.7% (12) ns
DM 10% (1) 14.4% (2) ns
HTN 60% (6) 64.4% (9) ns
CAD 40% (4) 57.1% (8) ns
Nicotine Abuse 100% (10) 92.9% (13) ns
Diameter of Aneurysm 7.0  1.8 6.8  1.3 ns
Preoperative Creatinine 1.3  0.47 1.2  0.36 ns
Creatinine Clearance 66.1  19.8 82.8  40.1 ns
Site of Cross-Clamping
Interrenal 70% (7) 33.3% (4)
Suprarenal 30% (3) 66.7% (10)
Changes in creatinine clearance over time.
Categories
Preoperative
creatinine
clearance (ml)
Postoperative
creatinine clearance
(ml)—day 7
Latest creatinine
clearance (mean
48  4 months/mL)
RLRV 66.1  19.8 41.9  27.0 47.1  20.2
LLRV 82.8  40.1 73.9  37.9 61.9  38.9
P-value  ns
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Objectives: The CardioMEMS EndoSure wireless
pressure sensor has been used to ensure exclusion of the
aortic sac during endovascular aortic repair (EVAR). How-
ever, little has been studied regarding the impact of the
pressure sensor on longitudinal axial imaging studies.
Methods: 79 patients underwent EVAR with implanta-
tion of the EndoSure device. All patients had post exclusion
sensor readings taken at the time of operation. All follow-up
visits were accompanied by EndoSure sensor reading and CT
scan. A total of 205 readings were matched with concurrent
CT scan for evaluation of aortic sac size and presence of
endoleak. Exclusion of the sacwas defined by a reduction of at
least 30% in either systolic or pulse pressure. Patients whose
sensor readings signaled non-exclusion were analyzed by uni-
variate analysis. Significance was set at p 0.05.
Results: Seventy-nine patients had complete data. The
group was 79.5% male, had an average age of 74.5  8.8
years and an average AAA diameter of 5.59  0.9 cm.
Twenty four of 79 patients had a EndoSure reading which
signaled non-exclusion of the aortic sac. Of these, four hada CT-verified type I or III endoleak. Overall the sensitivity
was 0.90 and the specificity was 0.31 for exclusion of the
sac. The positive predictive value was 0.95 and the negative
predictive value was 0.16. Patients with false negatives for
sac exclusion were significantly younger than those who
had a type I or III endoleak (71.6 1.7 vs 79.5 2.7, p
0.05). Also, male patients were significantly higher in false
negatives than in true type I or III endoleaks (85% vs 25%,
p  0.01). No other variables were significantly different
between groups. If EndoSure had been used as the sole
diagnostic test, it would have triggered 20 unnecessary CT
scans.
Conclusions:CardioMEMSEndoSurehas ahigh sensitiv-
ity andpositivepredictive value fordetecting sac exclusion.How-
ever, its high negative predictive value may lead to unnecessary
tests. This tends to affect younger andmale patients more often.
Author Disclosures: W. M. Bogey: Nothing to disclose;
C. A. Durham: Nothing to disclose; C. I. Jones: Nothing
to disclose; M. M. McNally: Nothing to disclose; F. M.
Parker: Nothing to disclose; C. S. Powell: Nothing to
disclose; M. C. Stoner: Nothing to disclose.
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Intensive Statin Therapy Is Associated With a Decrease
in Adverse Events and Death Following Carotid Revas-
cularization
Catherine K. Chang1, Chetan P. Huded2, Philip P. Good-
ney1, Brian W. Nolan1, Daniel B. Walsh1, Richard J. Pow-
ell1. 1Vascular Surgery, Dartmouth Hitchcock Medical
Center, Lebanon, NH; 2Dartmouth Medical School,
Hanover, NH
Objectives: To determine whether high dose statin
therapy is associated with a reduction in major adverse
events when compared to low/moderate dose or no statin
therapy following carotid revascularization.
Methods: A retrospective review was performed of 872
consecutive carotid endarterectomy (CEA) and carotid artery
stenting (CAS) procedures in 804 patients between 1/2003
and 3/2009. Patient demographics, co-morbidities, and clin-
ical outcomes were collected. High dose statin therapy was
defined as atorvastatin, simvastatin, pravastatin, lovastatin, or
fluvastatin at 80 mg/day or rosuvastatin at 20 mg/day start-
ing before or at time of procedure. The composite primary
outcome measure was all-cause mortality, stroke, any reinter-
vention, and recurrent stenosis 70% at 5 years. Statistical
analysis utilized a multivariate logistic regression model.
Results: At time of carotid revascularization, 216 pa-
tients were on no statin, 548 on a low or moderate dose, and
108 on a high dose statin. Hypertension, diabetes, coronary
artery disease, peripheral arterial disease, and congestive heart
failure were all significantly more prevalent in the high dose
group.Highdose statinswere associatedwith a decrease in the
composite endpoint from 19% to 11% (p  0.05) compared
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statin therapy was found to be protective of death, stroke,
reintervention or restenosis (OR0.41, 95%CI 0.21-0.81, p
0.01). In contrast, statin therapy of any dose was not associ-
ated with a reduction in the odds of any or all of these adverse
events. High dose statin therapy was also associated with a
64% reduction in the odds of death following CEA or CAS
(OR 0.36, 95% CI 0.15-0.86, p 0.02).
Conclusions: High dose statin therapy initiated before
carotid revascularization may have a protective effect in
reducing the incidence of death, stroke, reintervention, or
recurrent stenosis following CEA and CAS. Further studies
are needed to confirm these findings.
Author Disclosures: C. K. Chang: Nothing to disclose;
P. P. Goodney: Nothing to disclose; C. P. Huded: Noth-
ing to disclose; B. W. Nolan: Nothing to disclose; R. J.
Powell: Anges, Consulting fees or other remuneration
(payment); D. B. Walsh: Nothing to disclose.
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Coronary Artery Disease May Increase the Risk of
Cerebrovascular Accidents During Carotid Angio-
plasty and Stenting
Christine Chung, Tejas R. Shah, Hyunjoo Shin, Rami O.
Tadros, Sung yup Kim, Michael Marin, Peter Faries. Mount
Sinai Medical Center, New York, NY
Objectives: Patients at high surgical risk have been
treated using carotid angioplasty and stenting (CAS). How-
ever, appropriate patient selection for carotid interventions is
essential to optimize outcomes. We seek to determine the
impact of coronary artery disease (CAD) on embolic risk by
analyzing debris from protective filters during CAS.
Methods: 233 CAS procedures were performed from
2003-2009. Filters from 162 consecutive patients (CAD
[N  86], non-CAD [N  76]) were visualized by ste-
reomicroscopy along three perpendicular axes, and quanti-
fied through video imaging software. Due to particle shape
heterogeneity, individual particle sizes were determined by
greatest length. CAD was defined by history of MI, CHF,
CABG, or abnormal stress test.
Results: Mean patient age was 71.6 years, and 56.2%
were male. Debris was present in 134 (83%) filters. There was
a greater number of particles in CAD than non-CAD patients
(CAD: 12.6  13.0 vs non-CAD: 7.2  7.8, p  0.002).
CAD patients had smaller mean (CAD: 351m  216 vs
non-CAD: 429m 429, p 0.001) and minimum (CAD:
136m  115 vs non-CAD: 195m  237, p  0.001)
particle sizes compared with non-CAD patients.
Conclusions: CAD is associated with increased em-
bolic risk during CAS. Aside from greater particle number,
CAD patients release smaller-sized particles that may pose
increased neurologic risk by escaping capture by protection
devices. The benefits of a percutaneous carotid intervention
must be carefully weighed against the potential for worse
neurologic outcome in CAD patients referred for CAS.Author Disclosures: C. Chung: Nothing to disclose; P.
Faries: Nothing to disclose; S. Kim: Nothing to disclose; M.
Marin: Nothing to disclose;T. R. Shah: Nothing to disclose;
H. Shin: Nothing to disclose; R. O. Tadros: Nothing to
disclose.
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ectomy Compared to Carotid Artery Stenting: 10-Year
Analysis
Raja R. Gopaldas1, Faisal G. Bakaeen3, Scott A. LeMaire1,
Tam K. Dao2, Joseph Huh1, Danny Chu3, Joseph S. Co-
selli1. 1Baylor College of Medicine/Texas Heart Institute
at St. Lukes Episcopal Hospital, Houston, TX; 2Depart-
ment of Education Psychology, University of Houston,
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Objectives: The advent of Carotid Artery stenting
(CAS) has offered an alternative for carotid intervention in
high-risk patients. With the success met in single institution
centers, the indication is now being extended for low risk
patients. Our aim was to evaluate the nationwide outcomes
of CAS compared to open carotid endarterectomy (CEA.
Methods: From Nationwide Inpatient Sample data-
base 1998-2007, 1, 240, 816 patients underwent interven-
tions for carotid disease. Of these, 49, 750 underwent CAS.
Hierarchic multivariable regression models were used to
assess the independent effect of the operative strategy on
outcomes. Primary Outcomes were mortality, neurologic
and overall complications, while secondary outcomes were
discharge disposition and charges.
Results: Patients who underwent CAS were younger
(70.2  10.6 years vs 71  9.3 years; p  0.001) and had
higher Deyo scores (4.7  1.8 vs 4.4  1.4; p  0.001)
than CEA patients. Unadjusted After risk adjustment, CAS
was associated with 2.6 times higher mortality (p 0.001).
CAS was associated with 1 additional complication in 50
patients compared to CEA (p 0.001). Subgroup analysis
revealed that CAS was associated with higher odds of
